{"DataElement":{"publicId":"5123863","version":"1","preferredName":"Positron Emission Tomography Diagnostic Imaging Assessment Lymphoma Response Status","preferredDefinition":"A list categorizing lymphoma responses from a FDG-Positron Emission Tomography (FDG-PET) scan, a computerized image of the metabolic activity of body tissues used to determine the presence of disease.","longName":"LYMPHOMARESPONSE","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"2603748","version":"1","preferredName":"Positron Emission Tomography Diagnostic Imaging Assessment","preferredDefinition":"information related to a diagnostic assessment or evaluation using Positron Emission Tomography, a computerized image of the metabolic activity of body tissues used to determine the presence of disease.","longName":"PET_DXIMG_ASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2603746","version":"1","preferredName":"Positron Emission Tomography Diagnostic Imaging","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..","longName":"C17007:C16502","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnostic Imaging","conceptCode":"C16502","definition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7BF69C-E28A-5DAD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"ONEDATA","dateModified":"2007-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2261670","version":"1","preferredName":"Assessment","preferredDefinition":"Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber's)","longName":"C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2590-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-11","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-11","modifiedBy":"ONEDATA","dateModified":"2005-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7BF70A-994D-5E06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5123860","version":"1","preferredName":"Lymphoma FDG-PET Response Status","preferredDefinition":"A list categorizing lymphoma responses from a FDG-Positron Emission Tomography (FDG-PET) scan.","longName":"LYMPHOMARESPONSE","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"PMD","valueDescription":"Progressive metabolic disease","ValueMeaning":{"publicId":"5123861","version":"1","preferredName":"Progressive metabolic disease","longName":"5123861","preferredDefinition":"Progressive metabolic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BEACF9C-7232-656A-E050-BB89AD434BE5","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2BEACF9C-724B-656A-E050-BB89AD434BE5","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"ONEDATA","dateModified":"2016-02-16","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2BEACF9C-7255-656A-E050-BB89AD434BE5","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"ONEDATA","dateModified":"2016-02-16","deletedIndicator":"No"},{"value":"PMR","valueDescription":"PMR","ValueMeaning":{"publicId":"2721724","version":"1","preferredName":"PMR","longName":"2721724","preferredDefinition":"A decrease of metabolic tumor activity in all relevant lesions, based on a pre-defined threshold.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Metabolic Response","conceptCode":"C123609","definition":"A decrease of metabolic tumor activity in all relevant lesions, based on a pre-defined threshold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43EB8AD7-B6CE-5423-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-01-17","modifiedBy":"COOPERM","dateModified":"2020-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2BEACF9C-7269-656A-E050-BB89AD434BE5","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"ONEDATA","dateModified":"2016-02-16","deletedIndicator":"No"},{"value":"CMR","valueDescription":"Complete Metabolic Response","ValueMeaning":{"publicId":"4642714","version":"1","preferredName":"Complete Metabolic Response","longName":"4642714","preferredDefinition":"Complete Metabolic Response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A993A4A-3EC9-9BB3-E050-BB89AD430A21","latestVersionIndicator":"Yes","beginDate":"2014-12-19","endDate":null,"createdBy":"CORRALC","dateCreated":"2014-12-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2BEACF9C-727E-656A-E050-BB89AD434BE5","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"ONEDATA","dateModified":"2016-02-16","deletedIndicator":"No"},{"value":"Unevaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"2570773","version":"1","preferredName":"Unevaluable","longName":"2570773","preferredDefinition":"Unevaluable","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E182-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2BEACF9C-72A0-656A-E050-BB89AD434BE5","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"ONEDATA","dateModified":"2016-02-16","deletedIndicator":"No"},{"value":"NMR","valueDescription":"No Metabolic Response","ValueMeaning":{"publicId":"6074023","version":"1","preferredName":"No Metabolic Response","longName":"6074023","preferredDefinition":"The non-affirmative response to a question.: An evaluation of the metabolic response of the disease to the therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metabolic Response","conceptCode":"C123623","definition":"An evaluation of the metabolic response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6595BD80-B83E-6841-E053-F662850A8CC6","latestVersionIndicator":"Yes","beginDate":"2018-02-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-02-19","modifiedBy":"ONEDATA","dateModified":"2018-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6595BD80-B857-6841-E053-F662850A8CC6","beginDate":"2018-02-19","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-02-19","modifiedBy":"ONEDATA","dateModified":"2018-02-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BEACF9C-721E-656A-E050-BB89AD434BE5","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"MORENOC","dateModified":"2018-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Objective status at this eval","type":"Preferred Question Text","description":"Objective status at this evaluation","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2BEB1963-7D1F-138D-E050-BB89AD432C24","latestVersionIndicator":"Yes","beginDate":"2016-02-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-02-16","modifiedBy":"ZIEGLERK","dateModified":"2016-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}